Aesthetic Injectables – Market Insights – United States
Despite the initial negative repercussions of the COVID-19 pandemic, aesthetic injectable procedures have rebounded in the US and will continue to expand through 2031. Demand for aesthetic injectables will be spurred by the launch of numerous new products and expanded indications, as well as a growing patient pool, including nontraditional patient groups such as men and younger individuals.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for aesthetic injectables in the US from 2019 through 2031.
The COVID-19 pandemic has had both short- and long-term impacts on the aesthetic injectable market.
What impact has the COVID-19 pandemic had on the US aesthetic injectable market?
What new trends have emerged as a result of the pandemic?
At what pace is the market recovering?
Both major players and newer entrants are developing new and improved aesthetic injectable offerings, as well as seeking expanded indications for these products.
What trends are being seen in the market that are driving product innovations and improvements?
What kinds of products are being developed by competitors? When are they expected to be launched?
What product strategies are being employed by leaders in the aesthetic injectable space to remain competitive?
Mergers, acquisitions, and partnerships remain popular in the aesthetic injectable space.
What are the most notable M&As in this market and what competitive advantages have they provided to the companies involved?
Which companies have formed partnerships to develop products and expand their market presence? How have these agreements benefitted these competitors?
What are the strategies adopted by companies to bolster their presence in the US?
Table of contents
- Aesthetic Injectables - Market Insights - United States
- Abstract
- Executive Summary
- COVID-19 Updates
- Market Highlights
- Aesthetic Injectable Market, by Product Type, US (USD), 2019u20132031
- Aesthetic Injectable Market Landscape, US (USD), 2021 and 2031
- Competitive Highlights
- Aesthetic Injectable Revenue Market Share Rankings, by Product Type, US, 2021
- Competitive Insights
- Companies Mentioned
- Market Developments
- Recent Events in the Aesthetic Injectable Market, US
- Key Clinical Trials in the Aesthetic Injectable Market, US
- Emerging Products for the Aesthetic Injectable Market, US
- Procedures Covered
- Aesthetic Injectable Procedures Covered, US
- Products Covered
- Aesthetic Injectables Products Covered, US
- COVID-19 Updates
- Key Report Updates
- COVID-19 Analysis
- Market Impact
- COVID-19 Impact Assessment Summary, Aesthetic Injectable Market, US
- Major Market Forecast Changes and Assumptions
- Aesthetic Injectable Market, by Product Type, US (USD), 2019u20132031 (Excluding COVID-19 Impact)
- Aesthetic Injectable Market, by Product Type, US (USD), 2019u20132031 (Including COVID-19 Impact)
- Competitive Impact
- COVID-19 Competitive Factors and Strategies, Aesthetic Injectable Market, US
- COVID-19 Financial Impact and Competitor Insights
- Market Impact
- Aesthetic Injectable Market
- Market Highlights
- Key Content Updates
- US Aesthetic Injectable Market Drivers
- US Aesthetic Injectable Market Limiters
- Aesthetic Injectable Market, by Product Type, US (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Aesthetic Injectable Procedures, by Product Type, US, 2019u20132031
- Other Aesthetic Injectable Procedures, by Product Type, US, 2019u20132031
- Aesthetic Injectable Market, by Product Type, US (USD), 2019u20132031
- Other Aesthetic Injectable Market, US (USD), 2019u20132031
- Competitive Insights
- Allergan (an AbbVie company) Competitive Insights
- Galderma Competitive Insights
- Competitive Insights for Other Key Competitors
- Market Shares
- Aesthetic Injectable Revenue Market Shares, US, 2021
- Aesthetic Injectable Revenue Market Shares, by Product Type, US, 2021
- Market Developments
- Recent Events in the Aesthetic Injectable Market, US
- Key Clinical Trials in the Aesthetic Injectable Market, US
- Emerging Products for the Aesthetic Injectable Market, US
- Market Highlights
- Botulinum Toxin Market
- Market Highlights
- Key Content Updates
- US Botulinum Toxin Market Drivers
- US Botulinum Toxin Market Limiters
- BTX Market, US (USD), 2019u20132031
- Market Definitions
- Volume of BTX Product per Procedure, by Product Type
- Market Forecast Data
- BTX Market, US (USD), 2019u20132031
- Competitive Insights
- Market Shares
- BTX Revenue Market Shares, US, 2021
- BTX Revenue Market Shares, US, 2021
- Market Highlights
- Dermal Filler Market
- Market Highlights
- Key Content Updates
- US Dermal Filler Market Drivers
- US Dermal Filler Market Limiters
- Dermal Filler Market, by Material, US (USD), 2019u20132031
- Market Definitions
- Volume of Dermal Filler Product per Procedure, by Product
- Market Forecast Data
- Dermal Filler Procedures, by Material, US, 2019u20132031
- Dermal Filler Market, by Material, US (USD), 2019u20132031
- Dermal Filler Market Growth, by Material, US, 2020u20132031
- Competitive Insights
- Market Shares
- Dermal Filler Revenue Market Shares, US, 2021
- Dermal Filler Revenue Market Shares, by Material, US, 2021
- Market Highlights
- Appendix
- Abbreviations
- Bibliography
- Abbreviations
Meenu Sankar is a senior analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Clarivate, specializing in the large-joint reconstruction, dental, and aesthetics markets. Meenu holds a Bachelor’s degree in Pharmaceutical Sciences from Manipal University and a Master’s degree in Biomedicine from The University of Skövde, Sweden.
Follow Meenu on Twitter: @meenu_sankarDRG